Wararka

Qaranku khatar kama gelin karo waayeelka haddii la dejiyo siyaasadda COVID

By ZHANG ZHIHAO |CHINA DAILY |La cusbooneysiiyay: 2022-05-16 07:39

Waayeel dadka deegaanka ayaa laga baaray dhiigiisa ka hor inta aan la siin tallaalkiisaTalaalka covid-19Guri ku yaal degmada Dongcheng ee magaalada Beijing, May 10, 2022. [Sawirka/Xinhua]

Daboolista tallaalka sare ee waayeelka, maaraynta kiisas cusub iyo agab caafimaad, baaris hufan oo la heli karo, iyo daaweynta guriga ee COVID-19 ayaa ah qaar ka mid ah shuruudaha lagama maarmaanka u ah Shiinaha si ay u hagaajiso siyaasaddeeda jirta ee lagu xakameynayo COVID, khabiir sare oo cudurada faafa ah. ayuu yidhi.

Shuruudahan hordhaca ah la'aanteed, nadiifinta firfircooni ayaa weli ah istaraatiijiyadda ugu wanaagsan uguna mas'uulsan Shiinaha maadaama waddanku uusan halis gelin karin nolosha dadkeeda sare isagoo dejinaya tillaabooyinka ka hortagga faafitaanka xilli hore, ayuu yiri Wang Guiqiang, madaxa waaxda cudurrada faafa ee Isbitaalka Koowaad ee Jaamacadda Peking .

Dhul-weynaha Shiinaha ayaa soo sheegay 226 kiis oo gudaha laga soo gudbiyay oo la xaqiijiyay COVID-19 Sabtidii, kuwaas oo 166 ka mid ah ay ku sugnaayeen Shanghai 33 ka mid ahna ay ku sugnaayeen Beijing, sida lagu sheegay warbixinta Guddiga Caafimaadka Qaranka Axaddii.

Siminaar dadweyne Sabtidii, Wang, oo sidoo kale xubin ka ah kooxda khubarada qaranka ee daaweynta kiisaska COVID-19, wuxuu sheegay in dhowaan COVID-19 ka dillaacay Hong Kong iyo Shanghai ay muujisay in kala duwanaanshaha Omicron uu khatar weyn u keeni karo waayeel, gaar ahaan kuwa aan la tallaalin oo leh xaalado caafimaad oo hoose.

"Haddii Shiinuhu uu doonayo inuu dib u furo, Shuruudaha 1aad waa in la yareeyo heerka dhimashada COVID-19 dillaaca, habka ugu wanaagsan ee sidaas loo sameeyo waa tallaal," ayuu yidhi.

Xogta caafimaadka dadweynaha ee Maamulka Gaarka ah ee Hong Kong ayaa muujisay in Sabtidii, heerka guud ee dhimashada kiisaska cudurka Omicron uu ahaa 0.77 boqolkiiba, laakiin tiradaasi waxay gaartay 2.26 boqolkiiba kuwa aan la tallaalin ama kuwa aan dhamaystirin tallaalkooda.

Wadar dhan 9,147 qof ayaa ku dhintay cudurkii ugu dambeeyay ee magaalada ka dillaacay Sabtidii, badidood waa waayeel da'doodu tahay 60 iyo ka weyn.Kuwa ka weyn da'da 80, heerka dhimashadu wuxuu ahaa 13.39 boqolkiiba haddii aysan helin ama aysan dhamaystirin tallaalkooda.

Ilaa Khamiista, in ka badan 228 milyan oo da' ah oo da'doodu ka weyn tahay 60 jir oo ku nool dhul weynaha Shiinaha ayaa la tallaalay, kuwaas oo 216 milyan ka mid ah ay dhammeeyeen koorsada tallaalka oo dhammaystiran oo ku saabsan 164 milyan oo waayeel ah ay heleen tallaal xoojin ah, ayuu yidhi Komishanka Caafimaadka Qaranka.Dhul-weynaha Shiinaha waxa ku noolaa ilaa 264 milyan oo qof oo da'daan ah ilaa Noofambar 2020.

Ilaalinta muhiimka ah

"Balaadhinta tallaalka iyo kor u qaadida caymiska tallaalka ee waayeelka, gaar ahaan kuwa ka weyn da'da 80, ayaa gabi ahaanba muhiim u ah ka ilaalinta jirro daran iyo dhimasho," Wang ayaa yidhi.

Shiinuhu waxa uu durba soo saarayaa tallaalo si gaar ah loogu talagalay kala duwanaanshaha Omicron ee aadka la isugu gudbiyo.Horaantii bishaan, Shiinaha National Biotech Group, oo hoos taga Sinopharm, ayaa tijaabooyin caafimaad oo tallaalka Omicron ka bilaabay Hangzhou, gobolka Zhejiang.

Mar haddii kahortagga tallaalka coronavirus uu sii yaraan karo waqti ka dib, waxay aad ugu badan tahay oo lagama maarmaan u tahay dadka, oo ay ku jiraan kuwa horey u qaatay tallaalka xoojinta, in mar kale lagu kordhiyo difaacooda tallaalka Omicron mar uu soo baxo, Wang ayaa raaciyay.

Marka laga reebo tallaalka, Wang wuxuu sheegay inay muhiim tahay in la helo hannaan ka jawaab celin faafitaan oo COVID-19 oo aad loo hagaajiyay si loo ilaaliyo nidaamka daryeelka caafimaadka qaranka.

Tusaale ahaan, waa in ay jiraan sharciyo cad cad oo ku saabsan cidda iyo sida dadka loogu karantiilay guriga si shaqaalaha bulshadu ay si sax ah u maareeyaan oo ay ugu adeegaan dadka la karantiilay, iyo si aanay cisbitaaladu u buuxin qulqulka bukaannada cudurka qaba.

"Waa lama huraan in isbitaallada ay bixin karaan adeegyo caafimaad oo muhiim u ah bukaannada kale inta lagu jiro cudurka COVID-19.Haddii hawlgalkan ay carqaladeeyaan bukaanno cusub oo bukaanno ah, waxay keeni kartaa khasaare aan toos ahayn, waana wax aan la aqbali karin,” ayuu yidhi.

Shaqaalaha bulshadu waa inay sidoo kale la socdaan xaaladda dadka waayeelka ah iyo kuwa qaba baahiyaha caafimaad ee gaarka ah ee karantiil, si shaqaalaha caafimaadku ay si degdeg ah u bixiyaan gargaar caafimaad haddii loo baahdo, ayuu raaciyay.

Intaa waxaa dheer, dadweynuhu waxay u baahan doonaan daaweyn dheeraad ah oo la awoodi karo oo la heli karo, ayuu yiri Wang.Daawaynta monoclonal antibody-ka hadda jirta waxay u baahan tahay duritaanka xididada ee goobta cisbitaalka, iyo Pfizer's COVID kiniinka afka laga qaato ee Paxlovid wuxuu leeyahay qiimo aad u badan oo ah 2,300 yuan ($338.7).

"Waxaan rajeynayaa in badan oo ka mid ah dawooyinkayada, iyo sidoo kale daawada dhaqameed ee Shiinaha, ay door weyn ka ciyaari karaan la dagaallanka cudurka," ayuu yidhi."Haddii aan helno daaweyn awood leh oo la awoodi karo, markaa waxaan yeelan doonnaa kalsooni aan dib u furno."

Shuruudaha muhiimka ah

Dhanka kale, hagaajinta saxnaanta xirmooyinka is-baaritaanka antigen-ka ee degdega ah iyo ballaarinta helitaanka tijaabada aashitada nukliyeerka iyo awoodda heerka bulshada ayaa sidoo kale ah shuruudaha muhiimka ah ee dib u furitaanka, Wang ayaa yidhi.

"Guud ahaan marka loo hadlo, hadda ma ahan waqtigii Shiinaha uu dib u furi lahaa.Natiijo ahaan, waxaan u baahanahay inaan ilaalino istaraatiijiyada nadiifinta firfircoon oo aan ilaalino waayeelka arrimaha caafimaadka hoose leh, "ayuu yidhi.

Lei Zhenglong, oo ah agaasime ku-xigeenka Xafiiska Kahortagga iyo Xakamaynta Cudurrada ee Komishanka Caafimaadka Qaranka, ayaa ku celiyay Jimcihii in ka dib markii la dagaallamayay cudurka COVID-19 in ka badan laba sano, istiraatiijiyadda nadiifinta firfircooni waxay muujisay inay waxtar u leedahay ilaalinta caafimaadka bulshada, waana ikhtiyaarka ugu fiican ee Shiinaha marka loo eego xaaladda hadda jirta.